Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership

Oct 05, 06:12 PM
Headliner
Share
Subscribe

Jewel Jones warns that pharma catches patient disengagement too late, CSL and Alentis Therapeutics join Jiangsu Nhwa and Somnivera in a day of new licensing deals, and Corxel's Bo Liang calls GLP-1's leap to bariatric-surgery-level efficacy the biggest surprise in obesity medicine.

Share
Subscribe
Next
AI and Patient Recruitment: Can Predictive Promise Drive True Transformation?
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Key Findings of the NIAGARA and HIMALAYA Trials
by Pharmaceutical Executive